COVID-19 caused by SARS-CoV-2, is an international concern. This infection requires urgent efforts to develop new antiviral compounds. To date, no specific drug in controlling this disease has been identified. Developing the new treatment is usually time consuming, therefore using the repurposing broad-spectrum antiviral drugs could be an effective strategy to respond immediately. In this review, a number of broad-spectrum antivirals with potential efficacy to inhibit the virus replication via targeting the virus spike protein (S protein), RNA-dependent RNA polymerase (RdRp), 3-chymotrypsin-like protease (3CLpro) and papain-like protease (PLpro) that are critical in the pathogenesis and life cycle of coronavirus, have been evaluated as possible treatment options against SARS-CoV-2 in COVID-19 patients.
【저자키워드】 COVID-19, Drug repurposing, SARS-CoV-2, antiviral drugs, 【초록키워드】 Treatment, Efficacy, coronavirus, Pathogenesis, S protein, antiviral drugs, Infection, Antiviral compounds, 3CLpro, protease, Spike protein, antiviral drug, Papain-like protease, International, RdRP, RNA-dependent RNA polymerase, virus replication, broad-spectrum antivirals, PLPro, disease, Critical, COVID-19 patients, life cycle, (RdRp), effort, chymotrypsin, Papain, virus spike protein, broad-spectrum antiviral, effective, develop, inhibit, evaluated, Developing, respond, 【제목키워드】 Antiviral, SARS-CoV-2 replication, COVID-19 patient,